Add-on Acquisition • Life Science

Italfarmaco Acquires Lacer

On July 24, 2022, Italfarmaco acquired life science company Lacer

Acquisition Context

This is Italfarmaco’s 1st transaction in the Life Science sector.
This is Italfarmaco’s 1st transaction in Spain.

Explore All 3115 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	July 24, 2022
Target	Lacer
Sector	Life Science
Buyer(s)	Italfarmaco
Deal Type	Add-on Acquisition

Target Company

Lacer

Barcelona, Spain

Lacer is a pharmaceutical company that operates through two segments: personal care and prescription drugs. The company specializes in segments such as oral hygiene, the treatment of varicose veins, and hair loss. Lacer was formed in 1949 and is based in Barcelona, Spain.

Explore More Deals

Browse All 215,262 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Italfarmaco

Milan, Spain

Category	Company
Founded	1938
Sector	Life Science

DESCRIPTION

Italfarmaco is a multinational company that operates in Italy and abroad in the pharmaceutical and chemical-pharmaceutical sector, with products with a high therapeutic content that mainly fall into the cardiovascular, immuno-oncological, and gynecological areas. The company has modern and sophisticated industrial plants where it produces medicinal specialties in pre-filled syringes, sterile preparations for injection, oral, solid, and liquid products. Italfarmaco was formed in 1938 and is based in Milan, Spain.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
Country: Spain	1 of 1
Year: 2022	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Spain M&A - 2022 M&A